Target intelligence / Profile preview

RNA, U6 small nuclear 1120, pseudogene (RNU6-1120P)

Target
RNU6-1120P
Molecular classification
Other (classified as a pseudogene), Non-coding RNA (pseudogene of snRNA)
01

Overview

RNU6-1120P is a pseudogene corresponding to the U6 small nuclear RNA gene family, which plays a central role in the spliceosome assembly and pre-mRNA splicing, but as a pseudogene, RNU6-1120P does not produce the canonical small nuclear RNA and is generally considered nonfunctional. Pseudogenes are evolutionary relics of functional genes and, in the case of U6 pseudogenes, typically do not encode proteins, nor do they participate in enzymatic or receptor-driven mechanisms. While some pseudogenes can exert regulatory effects (such as acting as competitive endogenous RNAs for microRNAs or other non-coding regulatory roles), there is no current evidence that RNU6-1120P plays such a biological or therapeutic role. Most references to pseudogenes like RNU6-1120P highlight their nonfunctional status, although some pseudogenes in general can act as competitive endogenous RNAs or ceRNAs. However, specific evidence and functions for RNU6-1120P are lacking—so it should not be considered a drug target, biomarker, or relevant receptor/enzyme for therapeutic modulation.

Other names
RNU6-1120PU6 small nuclear RNA 1120 pseudogene
02

Mechanism of action

None established

03

Biological functions

None establishedRelated to RNA biology as a relic of snRNA gene
04

Disease associations

None convincingly established for RNU6-1120P
05

Safety considerations

None relevant; it is not therapeutically targeted
06

Biomarkers

None validated for patient selection or efficacy monitoring

Beyond the preview

Go deeper on RNA, U6 small nuclear 1120, pseudogene (RNU6-1120P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1120, pseudogene (RNU6-1120P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call